# Shilpa Medicare Ltd (SHILPAMED)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹474.65
Day Change: -0.35%
52W High: ₹500
52W Low: ₹259.5
Market Cap: ₹9,314 Cr

## Valuation
P/E: 42.18
P/B: 3.83
EPS: ₹11.29
Book Value: ₹124.44
Dividend Yield: 0%

## Returns
1Y Return: 19.15%

## Profitability
ROE: 0%
ROCE: 11.97%
Debt/Equity: 0.24
Revenue Growth: 28.3%
Profit Growth: 45.2%
EBITDA Margin: 26.4%
Operating Margin: 20.49%

## About
Shilpa Medicare Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Shilpa Medicare Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Announcement: Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:05.655Z
Price History Updated: 2026-05-18T22:58:28.338Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:28.338Z
Quant Updated: 2026-05-18T22:58:28.338Z
Sentiment Updated: 2026-05-18T22:58:28.338Z
Financials Status: current
Financials Updated: 2026-05-18T11:30:46.937Z
Financials Last Attempt: 2026-05-18T11:30:46.937Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2015)
Revenue: ₹571 Cr
Operating Profit: ₹116 Cr (OPM 20%)
Net Profit: ₹75 Cr
Tax: ₹95 Cr

## Annual P&L History
Mar 2015: Rev ₹571Cr | PAT ₹75Cr | OPM 20%
Mar 2016: Rev ₹614Cr | PAT ₹73Cr | OPM 21%
Mar 2017: Rev ₹719Cr | PAT ₹99Cr | OPM 21%

## Balance Sheet (Mar 2015)
Total Assets: ₹678 Cr
Total Liabilities: ₹678 Cr
Borrowings: ₹118 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Vishnukanth Chaturbhuj Bhutada B. Pharm, MD & Director
- Sharath Reddy Kalakota M.Pharma, VP of Projects & Operations and Whole-Time Director
- Alpesh Maheshkumar Dalal, Chief Financial Officer
- Pramod  Kumar, Senior Vice President of Technical
- Monish  Shah, Head of Investor Relations

---
Source: rupiya.io/stocks/shilpamed
Disclaimer: For research and education only. Not investment advice.